Finance (No. 2) Bill

Scott Arthur Excerpts

2nd reading
Tuesday 16th December 2025 Commons Chamber

[Seamus Logan]

I agree with my hon. Friend completely. I implore the Treasury to reconsider and hear what the hon. Member for Penrith and Solway (Markus Campbell-Savours) said, but if it does not, my party will bring forward a suitable amendment on Report.

Labour MPs have talked a big talk about how much money is going to Scotland, but I would like to ask them how much they are taking away from Scotland, whether it is through the APR, the energy profits levy, the excise duty on Scotch whisky or the national insurance hike. Once again, it feels like Scotland’s wealth and success are being used against it by an uncaring Westminster Government.

I want to turn to one other issue: NHS drug costs. They are not in the Finance Bill, but my point is that they should have been. I appreciate that you are giving me a bit of leeway, Madam Deputy Speaker. The new UK-US trade deal in medicines raises huge questions about where the money is coming from to pay for these increases in drugs costs. If the additional costs are to come from within existing NHS budgets—that is, through efficiency savings—I must ask the Government whether they have read the University of York’s impact assessment concerning excess deaths and negative impacts on cancer patients, gastroenterology and respiratory care in particular. If the additional costs are to come from the Treasury, where is this mentioned in the Budget, in this Finance Bill or in the accompanying Red Book? It is certainly not in the Bill, but it should have been. The OBR will be listening and watching, and will get to this in due course.

What does all this mean for Scotland in Barnett consequentials? Why has there been so little opportunity for parliamentary scrutiny of this smoke-and-mirrors deal? Transparency is needed on costs. The Health Secretary says £1 billion to £1.5 billion. The OBR says £3 billion, and £6 billion has been suggested by other commentators. Which is it? The Government hail it as a great deal for the UK, but the truth is that no matter where this money comes from—the Treasury or existing NHS funds—patients will ultimately pay the price for filling this pharma black hole. It looks like the UK Government are over a barrel on this, with drug companies threatening to pull out of investment in the UK, bullying from an increasingly erratic White House and creeping privatisation of the NHS. The Government need to provide some answers. I simply say to all Labour Members who have bragged this evening about what a wonderful Bill this is and what a wonderful Budget this has been: why are the polls showing that this Government are the least popular in history?

[Dr Scott Arthur (Edinburgh South West) (Lab)]

I thank the hon. Gentleman for giving way at such an opportune point. I respect the fact that he is here and that his political ambition is Scottish independence. The Government negotiated that trade deal with the United States, and it is one of the best deals any country in the world has. I find myself wondering what kind of deal an independent Scottish Government—perhaps led by the hon. Member for Angus and Perthshire Glens (Dave Doogan) sitting next to him or by John Swinney—could negotiate with Donald Trump. Would it be a better deal or a worse deal?

[Seamus Logan]

I am glad to hear that the hon. Member respects our desire for Scottish independence. I simply say to him: when will this Government respect the democratic will of the Scottish people?

I could go on to talk about energy and the coastal growth fund—two measures that, again, have particularly hurt my constituents—but I will leave it there.